Form 990 for tax year 2022
Filed by DAVOS ALZHEIMERS COLLABORATIVE INC.
Totals
- Total revenue
- $9,767,900
- Total expenses
- $8,101,186
- Contributions and grants received
- $9,767,900
- Grants paid
- $2,919,719
- Program service revenue
- $0
- Investment income
- $0
- Other revenue
- $0
- Total assets, end of year
- $14,995,945
- Total liabilities, end of year
- $1,586,998
- Net assets or fund balances, end of year
- $13,408,947
- Program services expenses (Part IX)
- $7,471,549
- Management and general expenses
- $547,537
- Fundraising expenses
- $82,100
- Program service expenses (Part III)
- $7,471,549
Program services were 92.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$9,767,900
-
1g · Noncash contributions included above
$493,900
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $1,829,209 · program services $1,829,209
-
3 · Grants to foreign organizations and individuals
total $1,090,510 · program services $1,090,510
-
11a · Fees: management
total $851,527 · program services $787,114 · management and general $63,795 · fundraising $618
-
11b · Fees: legal
total $275,339 · program services $254,511 · management and general $20,628 · fundraising $200
-
11c · Fees: accounting
total $124,455 · program services $115,240 · management and general $9,125 · fundraising $90
-
11g · Fees: other
total $3,324,512 · program services $3,044,433 · management and general $277,393 · fundraising $2,686
-
12 · Advertising and promotion
total $290,507 · program services $177,129 · management and general $40,399 · fundraising $72,979
-
13 · Office expenses
total $2,930 · program services $2,533 · management and general $385 · fundraising $12
-
17 · Travel
total $214,603 · program services $146,651 · management and general $67,557 · fundraising $395
-
19 · Conferences, conventions and meetings
total $68,761 · management and general $63,760 · fundraising $5,001
-
23 · Insurance
total $10,461 · program services $8,787 · management and general $1,631 · fundraising $43
-
24a · Other expenses: EQUIPMENT
total $12,170 · program services $10,223 · management and general $1,897 · fundraising $50
-
24b · Other expenses: SUBSCRIPTION FEES
total $6,202 · program services $5,209 · management and general $967 · fundraising $26
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $12,435,461 · end of year $14,926,469
-
3 · Pledges and grants receivable
end of year $16,547
-
9 · Prepaid expenses and deferred charges
beginning of year $7,590 · end of year $52,929
-
17 · Accounts payable and accrued expenses
beginning of year $696,930 · end of year $1,586,998
-
27 · Net assets without donor restrictions
beginning of year $11,146,121 · end of year $12,756,730
-
28 · Net assets with donor restrictions
beginning of year $600,000 · end of year $652,217
Mission and programs · 2022
Mission
DAC IS LEADING THE LARGEST GLOBAL RESPONSE OF ITS KIND, DRIVING SCIENTIFIC DISCOVERY AND ALIGNING HEALTH SYSTEMS TO HELP PEOPLE WORLDWIDE, INCLUDING THOSE IN LOW RESOURCED ENVIRONMENTS LEFT OUT OF PREVIOUS EFFORTS TO FIGHT ALZHEIMER'S. WE ARE COMMITTED TO TRANSFORMING ALZHEIMER'S RESEARCH, PREVENTION AND CARE THROUGH PROVEN PRIVATE-PUBLIC MODELS, SUCH AS GAVI, CEPI AND THE GLOBAL FUND.
Activities or mission (Part I)
SEE PART III LINE 1.
-
HEALTHCARE SYSTEM PREPAREDNESS - DAC IS INVESTING TO TRANSFORM THE WAY HEALTHCARE SYSTEMS WORLDWIDE DETECT, DIAGNOSE AND TREAT ALZHEIMER'S. THE GOAL IS TO TAKE ADVANTAGE OF FUTURE INNOVATIONS TO IMPROVE THE QUALITY OF LIFE FOR PEOPLE EVERYWHERE. IN 2022, DAC CONTINUED TO ADVANCE 7 FLAGSHIP PROJECTS IN 6 COUNTRIES AS WELL AS SUPPORT AND MONITOR THE EXECUTION OF THE INITIAL GRANTS PROGRAM (12 GRANTS IN TOTAL).
Expenses $5,968,731 · Grants $2,419,719
-
GLOBAL COHORTS - DAC IS BUILDING GLOBAL COHORTS TO ADVANCE UNDERSTANDING OF ALZHEIMER'S AMONG DIVERSE POPULATIONS. THIS DATA WILL PROVIDE THE FOUNDATION FOR IDENTIFYING NEW BIOMARKERS AND DEVELOPING TARGETED TREATMENTS THAT WORK FOR PEOPLE WORLDWIDE. IN 2022, DAC RECRUITED 23 COHORTS AROUND THE GLOBE. AS A BASIS TO BEGIN CONTRACTING, DAC ALSO EXECUTED A MEMORANDUM OF UNDERSTANDING (MOU) WITH A COHORT MANAGED BY AGA KHAN UNIVERSITY IN NAIROBI, KENYA. OUTREACH TO COHORTS WERE TARGETED THAT HAVE THE STRONGEST ALIGNMENT WITH THE SCIENTIFIC PLAN AND ACCESS TO THE TARGETED MEASUREMENTS. ALSO IN 2022, DAC PROVIDED A LETTER OF INTENT TO THE NATIONAL INSTITUTES ON HEALTH OUTLINING A 5-YEAR, $50M USD GRANT THAT WAS POSITIVELY REVIEWED.
Expenses $840,903
-
GLOBAL CLINICAL TRIALS - DAC IS BUILDING A GLOBAL NETWORK OF CLINICAL TRIAL SITES AND A SUPPORTING TECHNOLOGY PLATFORM TO REDUCE THE COST AND TIME OF BRINGING NEW TREATMENTS TO MARKET. DAC DEVELOPED A NETWORK OF MORE THAN 30 EUROPEAN SITES ORGANIZED FOR ACCELERATING STUDIES AND IMPLEMENTING NOVEL TRIAL DESIGNS AND SECURED A PHARMACEUTICAL COMPANY SPONSOR.
Expenses $661,915 · Grants $500,000
As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
George VradenburgGEORGE VRADENBURG
CHAIR & PRESIDENT
- Total calculated
- $0
- Hours/week
- 20
-
Andrew HolzapfelANDREW HOLZAPFEL
COO (SEE SCHEDULE O)
- Total calculated
- $0
- Hours/week
- 30
-
Freda Lewis HallFREDA LEWIS HALL
TREASURER
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
-
$859,938
SCIENTIFIC RESEARCH FOR ALZHEIMER'S DISEASE
-
$522,694
SCIENTIFIC RESEARCH FOR ALZHEIMER'S DISEASE
-
UNIVERSITY OF WASHINGTON
$250,177
SCIENTIFIC RESEARCH FOR ALZHEIMER'S DISEASE
-
$124,911
SCIENTIFIC RESEARCH FOR ALZHEIMER'S DISEASE
-
AVANT INSTITUTE
$64,644
SCIENTIFIC RESEARCH FOR ALZHEIMER'S DISEASE
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
DAVOS ALZHEIMER'S COLLABORATIVE (GENEVE)
N/A · PROMOTE HEALTH BY DEVELOPING RESEARCH ON BRAIN HEALTH. · SZ · controlled entity
Directly controlled by DAC
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 29 September 2023
- IRS schema version
- 2022v5.0
- Source object
- 202332729349300423
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.